IMMUNIC, INC. Quarterly Nonoperating Income (Expense) in USD from Q1 2013 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Immunic, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from Q1 2013 to Q3 2024.
  • Immunic, Inc. Nonoperating Income (Expense) for the quarter ending September 30, 2024 was $1.36M, a 69.5% increase year-over-year.
  • Immunic, Inc. Nonoperating Income (Expense) for the twelve months ending September 30, 2024 was -$1.1M, a 124% decline year-over-year.
  • Immunic, Inc. annual Nonoperating Income (Expense) for 2023 was $5.61M.
  • Immunic, Inc. annual Nonoperating Income (Expense) for 2022 was -$919K, a 28.2% increase from 2021.
  • Immunic, Inc. annual Nonoperating Income (Expense) for 2021 was -$1.28M, a 126% decline from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)
* An asterisk sign (*) next to the value indicates that the value is likely invalid.